During the investigation of the action of SV40 virus by means of fusion of SV40-transformed cells with virus-susceptible monkey kidney cells,' it became apparent that SV40-induced complement fixation antigen (ICFA)2 was transmitted to the nuclei of the nontransformed cells whether or not fusion between the two systems resulted in the isolation of infectious virus.' 3 This was not surprising, since the mechanism of ICFA synthesis apparently is unrelated to the synthesis of viral protein and infectious virus, and the antigen is found in many non-virus-yielding transformed cells. As a corollary of these observations, an investigation of transmission of ICFA in heterokaryocytes to nuclei originating from cells resistant to SV40 infection became of interest. Further, a study of the mechanism of the transmission of ICFA was instituted to elucidate the process of its intracellular synthesis.
During the investigation of the action of SV40 virus by means of fusion of SV40-transformed cells with virus-susceptible monkey kidney cells,' it became apparent that SV40-induced complement fixation antigen (ICFA)2 was transmitted to the nuclei of the nontransformed cells whether or not fusion between the two systems resulted in the isolation of infectious virus.' 3 This was not surprising, since the mechanism of ICFA synthesis apparently is unrelated to the synthesis of viral protein and infectious virus, and the antigen is found in many non-virus-yielding transformed cells. As a corollary of these observations, an investigation of transmission of ICFA in heterokaryocytes to nuclei originating from cells resistant to SV40 infection became of interest. Further, a study of the mechanism of the transmission of ICFA was instituted to elucidate the process of its intracellular synthesis.
Materials and Methods.-Tissue cultures: Table 1 lists cell types used for fusion experiments. The origin and history of SV40-transformed human, monkey, and hamster cell lines were described previously.' ICFA (T-antigen)2 was present in cell nuclei of all these lines, referred to as "donor" lines. The "recipient" cells described in Table 1 were characterized by the absence of ICFA in their nuclei. This was confirmed repeatedly during each fusion experiment.
All cells were grown in double-strength Eagle's basal medium in Earle's balanced salt solution with 10% fetal calf serum and aureomycin (50 Ag/ml).
Technique of cell fusion: The fusion technique was essentially similar to the one described previously.' Recipient cells were labeled with 0.2 uc/ml thymidine methyl-Ha (specific activity 14.5 c/mM) for Transmission of ICFA was also unrelated to the susceptibility of the recipient cell types to SV40 infection, since ICFA was transmitted not only to African green monkey kidney (AGMK) and CV-1 cells, which are susceptible to infection, but also to mule4 and hamster embryo cells, both of which are much more resistant to infection than AGMK and CV-1 cells. Autoradiographic studies showed that 24 hours after fusion of various types of donor and recipient cells, approximately 30-50 per cent of the multinucleated cells are true heterokaryocytes. Figure 2 shows the same cells after ICFA staining (A, C) and autoradiography (B, D). In the cell in Figure 2A , two of the five ICFA-positive nuclei are labeled (B) and are from the recipient cells. In Figure 2C , one of the six ICFA-positive nuclei on the lower left is heavily labeled (D) and is clearly a nucleus from a recipient cell.
Effect of metabolic inhibitors on transfer of ICFA: Since synthesis of ICFA in the nuclei of the donor cells must be directed in the course of numerous passages by some part of the viral genome dividing in synchrony with the cells, transmission of ICFA in heterokaryocytes may be mediated by the passage of this viral genome from the donor to the recipient nucleus. Transmission may also occur through the passive transfer of already synthesized antigen or by transfer of mRNA to the recipient nuclei, followed by synthesis of ICFA. ICFA may also be synthesized in the cytoplasm of the heterokaryocytes and then taken up by the recipient nucleus without passage of the mRNA from the donor to the recipient nucleus. In order to investigate these possibilities, experiments with metabolic inhibitors were initiated. To investigate the possibility that previously synthesized antigen is passively transferred from one nucleus to another in a heterokaryocyte, fusion was performed in the presence of 30 ug/ml of cycloheximide, a protein synthesis inhibitor. In this experiment, F5-1 and AGMK cells were fused in the presence of 30 ug/ml of cycloheximide; the inhibitor was then left in the medium at the same concentration for 26 hours of incubation. In another set of cultures, the cells were fused in the absence of the inhibitor; cycloheximide was then added, either immediately hours with cycloheximide. It can be noted that, in contrast to Figure 2A , B, C, and D, the labeled "recipient" cells' nuclei do not show ICFA-fluorescence.
Inhibition of ICFA transmission by cycloheximide seemed to indicate that protein synthesis may be necessary for ICFA transmission.
In order to investigate the role of mRNA in ICFA transmission, F5-1 cells and HE cells were fused in the presence of actinomycin D (Fig. 4) . Because of the Since, in these experiments, actinomycin was added to the cultures at the time of fusion, we may conclude that inhibition of mRNA synthesis occurred at the level of the donor nucleus. However, it was still impossible to distinguish whether synthesis of ICFA took place in the cytoplasm of the heterokaryocyte under the direction of mRNA from the donor nucleus, or in the recipient nucleus after internuclear passage of mRNA. In order to test these two possibilities, an experiment was designed in which cycloheximide was removed from the fused cultures after a short period (5 or 9 hr) (Fig. 5) and washing of the cultures, normal medium was added, and the cells were examined for internuclear ICFA transmission at various time intervals. ----If, during the period of inhibition of protein synthesis, passage of mRNA had occurred to the recipient nucleus, resumption of ICFA synthesis following removal of inhibitor would rather rapidly occur. This, as shown in Figure 5 , was not the case, since the appearance of ICFA in the recipient nuclei in heterokaryocytes was gradual. Thus, either we are dealing with an unstable messenger, or ICFA is being produced in the cytoplasm of the heterokaryocytes and the finished product is slowly taken up by the recipient nucleus.
Discussion.-Analysis of the effect of metabolic inhibitors on transmission of ICFA which takes place in heterokaryocytes produced through fusion of ICFApositive SV40-transformed donor cells with ICFA-negative recipient cells indicates that replication of the gene directing ICFA synthesis is not necessary for ICFA transmission from the donor to the recipient nucleus. It is also highly improbable that a previously synthesized antigen is passively transferred from one nucleus to another since, in this case, the presence of cycloheximide would not have inhibited transfer. Our results showing the effective blocking of internuclear ICFA transmission by actinomycin D are similar to the results obtained by others5 that actinomycin definitely inhibits ICFA formation after exposure of AGMK cells to SV40 virus.
The site of synthesis of ICFA protein is a matter of conjecture as long as it is not known whether synthesis of any protein of this type may take place in the nucleus. Although ICFA is localized by means of ferritin-conjugated antibody only in the nucleus of an SV40-infected cell, and not in its cytoplasm ,7 the higher concentration of the antigen in the nucleus may account for its visibility; a lower concentration in the cytoplasm would not be visible by this type of observation. ICFA apparently does not represent a "shuttle cytonucleoprotein" similar to the one described by Byers et al.,8 since it cannot transfer by simple diffusion as a preformed product. It is most probable that ICFA, similarly to the adenovirus 2-coded protein,9 is synthesized in the cytoplasm of a heterokaryon under the direction of mRNA from the nucleus of the transformed donor cell; the finished product is then "taken up" by the recipient nuclei. This suggests that the absence of viral coat protein in these nuclei cannot be ascribed to their inability to take up proteins synthesized outside the nucleus. Within this context it is doubtful that presence of ICFA in the nucleus may per se be considered as a hallmark for the transformation of the cells.
Summary.-Fusion of transformed cells with cells of various origins results in the transmission of ICFA to the recipient nuclei. This transmission is insensitive to FUdR, indicating that DNA synthesis is not necessary. Actinomycin D inhibits ICFA transmission, indicating the necessity of new mRNA synthesis for transmission. Cycloheximide also inhibits the transmission of ICFA, indicating that protein synthesis is necessary for transmission; simple diffusion does not account for the observed internuclear protein migration.
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